已收盤 11-20 16:00:00 美东时间
-0.020
-0.98%
11月19日,CytomX Therapeutics(CTMX)收跌3.09%,报1.88美元,成交额863.67万美元,市值4.1亿美元。 行情数据 • 开盘...
11-19 07:13
11月18日,CytomX Therapeutics(CTMX)收跌2.27%,报1.94美元,成交额419.24万美元,市值4.23亿美元。 行情数据 • 开...
11-18 07:10
CytomX Therapeutics announced the achievement of a preclinical milestone in its collaboration with Regeneron, triggering a $5 million milestone payment. The partnership, established in 2022 and expanded in June 2026, combines CytomX's PROBODY® masking technology with Regeneron's Veloci-Bi® bispecific antibody platform to develop conditionally active bispecifics that remain inactive until activated in the tumor microenvironment. This approach aims...
11-17 21:15
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
11月10日,CytomX Therapeutics(CTMX)收跌9.59%,报1.98美元,成交额2640.37万美元,市值4.31亿美元。 行情数据 •...
11-10 07:12
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
11-09 14:00
最新财报显示,CytomX Therapeutics 2026财年第3季度实现: 营业收入:168.8万美元 同比:下降71.69% 每股收益:-0.09美元...
11-07 08:00
Wedbush analyst Robert Driscoll maintains CytomX Therapeutics (NASDAQ:CTMX) with a Outperform and raises the price target from $11 to $12.
11-07 00:51
CytomX Therapeutics (NASDAQ:CTMX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benz...
11-06 06:54
11月3日,CytomX Therapeutics(CTMX)收跌4.7%,报2.23美元,成交额2095.93万美元,市值4.86亿美元。 行情数据 • 开盘...
11-03 07:05